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PAST
For 9–13% of patients with gastric cancer who under-
went gastrectomy with curative intent, the resection
margins are tumor-positive.1 It is important to gain insight
about which patients are at risk for an incomplete tumor
resection. Therefore, our study was designed to evaluate
the factors associated with incomplete tumor removal.2
Previous studies also showed that higher hospital vol-
ume is associated with improved surgical quality and
outcome. This has resulted in centralization of gastric
cancer surgery. In 2016, 9 of 22 hospitals were low-volume
hospitals for gastrectomy.3 The present study also evalu-
ated whether an incomplete tumor resection is associated
with hospital volume.
PRESENT
This Dutch cohort study showed that patients with
advanced gastric cancers (i.e., involving the entire stom-
ach, advanced TNM-stage and diffuse-type gastric cancer)
are at risk for incomplete tumor removal. These risk factors
may lead to a change in surgical strategy. For example, an
extra wide tumor resection margin may be the target or
intraoperative frozen-section analysis may prevent incom-
plete tumor removal. In addition, when it is anticipated that
the proximal margin at the esophagus or the duodenum is at
risk, it may be indicated to refer patients to hospitals where
esophageal and/or hepatobiliary surgery is performed.
Another important finding in this study was that low
annual hospital volume (\ 20 resections per year) was
associated with a higher risk for incomplete tumor removal
compared with middle- and high-volume hospitals. This
finding may point toward the need for further centralization
of gastric cancer surgery or to discuss all patients in a
multidisciplinary team of gastric cancer experts.4
FUTURE
Unfortunately, due to the retrospective design of this
study, the influence of treatment-related factors, such as
neoadjuvant chemotherapy and the surgical approach on
the completeness of the resection, could not be evaluated.
A strength of this study was the nationwide coverage of the
database allowing assessment of national performance.
However, the use of a national database also has limita-
tions. Because the data for this study were retrieved from
the database of the Dutch Upper Gastrointestinal Cancer
Audit, some surgical details were lacking. This national
audit includes outcomes that are used to evaluate and
compare performances between hospitals. Because it is
time-consuming to register surgical details, these are not
registered in the audit. To further evaluate these surgical
details, we have recently started another study. In this
study, specific data regarding surgical details and treatment
details will be collected.
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